Rajiv Shukla Purchases 8,680 Shares of Carmell Co. (NASDAQ:CTCX) Stock

Carmell Co. (NASDAQ:CTCXGet Free Report) CEO Rajiv Shukla acquired 8,680 shares of the business’s stock in a transaction that occurred on Thursday, April 4th. The stock was purchased at an average price of $2.88 per share, for a total transaction of $24,998.40. Following the completion of the transaction, the chief executive officer now owns 57,206 shares in the company, valued at $164,753.28. The acquisition was disclosed in a document filed with the SEC, which is available through this hyperlink.

Rajiv Shukla also recently made the following trade(s):

  • On Wednesday, May 22nd, Rajiv Shukla purchased 4,051 shares of Carmell stock. The stock was purchased at an average price of $2.41 per share, for a total transaction of $9,762.91.
  • On Monday, May 20th, Rajiv Shukla acquired 1,172 shares of Carmell stock. The stock was acquired at an average cost of $2.22 per share, with a total value of $2,601.84.

Carmell Trading Down 1.6 %

Shares of CTCX stock opened at $2.46 on Thursday. Carmell Co. has a 1 year low of $1.70 and a 1 year high of $13.31. The stock has a fifty day moving average of $2.35 and a two-hundred day moving average of $2.91.

Institutional Investors Weigh In On Carmell

A number of hedge funds and other institutional investors have recently modified their holdings of CTCX. Meteora Capital LLC acquired a new position in Carmell during the 3rd quarter valued at about $6,416,000. Cookson Peirce & Co. Inc. bought a new position in shares of Carmell in the third quarter valued at approximately $54,000. Linden Advisors LP acquired a new position in shares of Carmell during the third quarter valued at approximately $270,000. Finally, Hubbell Strickland Wealth Management LLC bought a new stake in Carmell during the first quarter worth approximately $32,000. 24.22% of the stock is currently owned by institutional investors.

Carmell Company Profile

(Get Free Report)

Carmell Corporation operates as a bio-aesthetics company. The company utilizes Carmell Secretome to support skin and hair health. Its Carmell Secretome consists of a potent cocktail of growth factors and proteins extracted from allogeneic human platelets sourced from tissue banks. The company also developed a microemulsion formulation that enables delivery of lipophilic and hydrophilic ingredients without relying on the Foul Fourteen, 14 potentially harmful excipients that are commonly used by other companies to impart texture, stability, and other desirable physicochemical attributes to cosmetic products.

See Also

Insider Buying and Selling by Quarter for Carmell (NASDAQ:CTCX)

Receive News & Ratings for Carmell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carmell and related companies with MarketBeat.com's FREE daily email newsletter.